EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+2.08%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.08B
AUM Growth
+$1.08B
(-12%)
Cap. Flow
-$141M
Cap. Flow
% of AUM
-13.03%
Top 10 Holdings %
Top 10 Hldgs %
53.14%
Holding
103
New
19
Increased
15
Reduced
30
Closed
24
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$32M |
| 2 |
Community Health Systems
CYH
|
$21.9M |
| 3 |
Organon & Co
OGN
|
$21.2M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$17.6M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$17.1M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$71.3M |
| 2 |
GSK
GSK
|
$30.3M |
| 3 |
TG Therapeutics
TGTX
|
$26.9M |
| 4 |
Elevance Health
ELV
|
$20.5M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$17.2M |
Sector Composition
| 1 | Healthcare | 90.41% |
| 2 | Industrials | 1.59% |
| 3 | Financials | 0.07% |
| 4 | Consumer Discretionary | 0% |
